Diska LLC

Diska LLC produces a range of medical devices, including single-use nitrile and vinyl examination gloves for medical and treatment use, reusable manual blood lancing devices for capillary blood sampling, portable electronic sphygmomanometers for blood pressure measurement, pulse oximeters for oxygen saturation monitoring, electronic stand-on floor scales for weight assessment, and home-use glucose monitoring systems for continuous blood glucose tracking. These devices are designed for clinical, home, and treatment environments.

Diska LLC is based in the United States. The company’s headquarters and operations are located within the country, aligning its manufacturing and regulatory compliance with U.S. standards.

Diska LLC’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for each device’s identification, aiding in post-market surveillance and compliance tracking under U.S. regulations.

Diska LLC’s devices are classified under FDA regulations as either Class I or Class II. Class I devices generally pose minimal risk and require general controls, while Class II devices involve a higher level of risk and may require special controls to ensure safety and effectiveness. The classification depends on the device’s intended use and potential health impact.

Diska LLC’s home-use glucose monitoring systems are intended for continuous blood glucose tracking in personal settings, unlike their other devices which focus on procedural or diagnostic tasks like blood pressure measurement, pulse oximetry, or weight assessment. These systems are designed for patient self-monitoring, requiring compliance with in vitro diagnostic (IVD) regulations to ensure accuracy and reliability in home environments.